Report - Slide 1 Roger Ulrich, Ph.D., Fellow ATS Calistoga Pharmaceuticals, 2006-2011 Acerta Pharma, 2013- The Development of a Novel Lipid Kinase Inhibitor, Idelalisib.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form